According to 2016 WHO classification of gliomas [25], grade II/III gliomas can be grouped into three subtypes: IDH-wildtype, IDH-mutant/1p19q-codeleted and IDH-mutant/non-1p19q-codeleted gliomas. This evidence concerns the gene IDH1 and central nervous system cancer.